RxDoctor Payments Data
★ My doctorsLook up a doctor →

Mayur Maniar, MD

Neurology · Sunrise, FLNPI 1548211204

Payments from drug & device makers

$13,943in general payments, 2019–2025

Across 763 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • UCB, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Novartis$595
  • Johnson & Johnson$590
  • Lilly USA, LLC$474
  • plus $6K from 49 others

What the payments were for

  • Speaking & faculty fees$2112%
  • Food & beverage$13,43296%
  • Education$2992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)180$2,592
UCB, Inc.85$1,994
Teva Pharmaceuticals USA, Inc.62$1,662
Novartis51$595
Johnson & Johnson(2 entities)33$590
Lilly USA, LLC27$474
Amgen(2 entities)22$452
Sanofi18$418
Eisai Inc.24$362
AstraZeneca(2 entities)13$293
EMD Serono, Inc.13$274
SK Life Science, Inc.11$268
Sunovion Pharmaceuticals Inc.13$244
Acorda Therapeutics, Inc13$230
Lundbeck LLC9$229
Biohaven Pharmaceutical Holding Company Ltd.14$223
Jazz Pharmaceuticals Inc.10$219
Upsher-smith Laboratories LLC15$211
Supernus Pharmaceuticals, Inc.18$194
Bristol Myers Squibb11$193
Mallinckrodt Enterprises LLC7$178
Biohaven Pharmaceuticals, Inc.17$175
Pfizer8$166
Biogen10$155
Argenx US, Inc.5$135
Neurelis, Inc.6$135
Tanabe Pharma America, Inc.5$116
Otsuka America Pharmaceutical, Inc.4$97
Greenwich Biosciences, Inc.7$97
Octapharma USA, Inc.6$89
Livanova USA, Inc.5$81
Neurocrine Biosciences, Inc.4$69
Zyla Life Sciences, Inc.3$64
Sumitomo Pharma America, Inc.3$61
Aquestive Therapeutics, Inc.3$58
Takeda Pharmaceuticals U.S.A., Inc.2$56
Axsome Therapeutics, Inc.2$49
MDD US Operations, LLC3$45
Amneal Pharmaceuticals LLC2$43
Banner Life Sciences, LLC2$39
Aprecia Pharmaceuticals, LLC2$34
Harmony Biosciences LLC1$32
Grifols USA, LLC2$31
CSL Behring1$25
Vanda Pharmaceuticals Inc.1$25
Merz Pharmaceuticals, LLC1$21
E.r. Squibb & Sons, L.L.C.1$21
Corium, LLC1$20
Vertical Pharmaceuticals, LLC1$19
Adamas Pharmaceuticals, Inc.1$17
Sanofi-aventis U.S. LLC1$16
Promius Pharma LLC1$16
Currax Pharmaceuticals LLC1$14
Scilex Pharmaceuticals Inc.1$14
Avion Pharmaceuticals1$13

How this compares

$13,943 in reported general payments places this provider in the 70th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$20,475
Medicare patients
37
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Sunrise

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →